Prof. John F. Gilmer is a Professor of Pharmaceutical Chemistry in the School of Pharmacy & Pharmaceutical Sciences at Trinity College Dublin (TCD). His research centres on enzyme inhibitors, bile acid biology, and translational medicinal chemistry, particularly in liver disease and inflammatory conditions. He has published extensively (98+ peer-reviewed papers) and holds patents for therapeutic compounds. He also co-founded Solvotrin Therapeutics, bridging academic discovery and biotech innovation.
Prof. John F. Gilmer is a Professor of Pharmaceutical Chemistry in the School of Pharmacy & Pharmaceutical Sciences at Trinity College Dublin (TCD). His research centres on enzyme inhibitors, bile acid biology, and translational medicinal chemistry, particularly in liver disease and inflammatory conditions. He has published extensively (98+ peer-reviewed papers) and holds patents for therapeutic […]
Last Updated:
Research Areas:
Research Programmes
Related News

Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...

New €31.6 million ARC Hub for Therapeutics to turn breakthrough Irish research into therapies and companies
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
